Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HIV glycosylation: what does it portend?

× No keyword cloud information.

16 in total

1. Female genital tract shedding of CXCR4-tropic HIV Type 1 is associated with a majority population of CXCR4-tropic HIV Type 1 in blood and declining CD4(+) cell counts.

Authors: Richard E Haaland; Sharon T Sullivan; Tammy Evans-Strickfaden; Jeffrey L Lennox; Clyde E Hart
Journal: AIDS Res Hum Retroviruses Date: 2012-03-23 Impact factor: 2.205

2. Glycan-Dependent Neutralizing Antibodies Are Frequently Elicited in Individuals Chronically Infected with HIV-1 Clade B or C.

Authors: Yehuda Z Cohen; Christy L Lavine; Caroline A Miller; Jetta Garrity; Brittany R Carey; Michael S Seaman
Journal: AIDS Res Hum Retroviruses Date: 2015-08-05 Impact factor: 2.205

3. A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.

Authors: Michael D Alpert; Lisa N Heyer; David E J Williams; Jackson D Harvey; Thomas Greenough; Maria Allhorn; David T Evans
Journal: J Virol Date: 2012-08-29 Impact factor: 5.103

4. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.

Authors: R A Ogert; M K Lee; W Ross; A Buckler-White; M A Martin; M W Cho
Journal: J Virol Date: 2001-07 Impact factor: 5.103

5. Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus.

Authors: José M Martinez-Navio; Ronald C Desrosiers
Journal: J Virol Date: 2012-09-19 Impact factor: 5.103

6. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.

Authors: Cheryl Pikora; Christine Wittish; Ronald C Desrosiers
Journal: J Virol Date: 2005-10 Impact factor: 5.103

7. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.

Authors: R I Connor; B T Korber; B S Graham; B H Hahn; D D Ho; B D Walker; A U Neumann; S H Vermund; J Mestecky; S Jackson; E Fenamore; Y Cao; F Gao; S Kalams; K J Kunstman; D McDonald; N McWilliams; A Trkola; J P Moore; S M Wolinsky
Journal: J Virol Date: 1998-02 Impact factor: 5.103

8. The Patterns of Coevolution in Clade B HIV Envelope's N-Glycosylation Sites.

Authors: Swetha Garimalla; Thomas Kieber-Emmons; Anastas D Pashov
Journal: PLoS One Date: 2015-06-25 Impact factor: 3.240

9. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences.

Authors: B T Korber; K J Kunstman; B K Patterson; M Furtado; M M McEvilly; R Levy; S M Wolinsky
Journal: J Virol Date: 1994-11 Impact factor: 5.103

10. Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines.

Authors: Baptiste Aussedat; Yusuf Vohra; Peter K Park; Alberto Fernández-Tejada; S Munir Alam; S Moses Dennison; Frederick H Jaeger; Kara Anasti; Shelley Stewart; Julie H Blinn; Hua-Xin Liao; Joseph G Sodroski; Barton F Haynes; Samuel J Danishefsky
Journal: J Am Chem Soc Date: 2013-08-22 Impact factor: 15.419